Isolation of biologically active metabolites from Bougainvillea spectabilis Willd. cultivated in Egypt by El Deeb, Kadriya S. et al.
Deeb et al. DOI:
Submitted to:
International Journal of Phytomedicine
RESEARCH ARTICLE
Isolation of biologically active metabolites 
from Bougainvillea spectabilis Willd.
cultivated in Egypt
Kadriya S El Deeb1, Hanaa H Eid1, Amany A Sleem1, Ghada F Metwally2* and Menna B Abdel 
Halim2
Abstract
Bougainvillea spectabilis Willd. is an ornamental plant cultivated in tropical, subtropical regions and other places as Egypt.
The present study aimed to perform bioassay guided fractionation and isolation of some of the bioactive compounds from the
Egyptian cultivate. The total ethanol extracts of the leaves (T.ET.L.), stems (T.ET.S.) and flowers (T.ET.F.) were screened for some
pharmacological activities viz. in vivo anti-oxidant and anti-hepatotoxic, in addition to in vitro cytotoxic activities. The anti-oxidant
effect was assessed by measuring serum glutathione level (GSH) in alloxan-induced diabetic rats. The anti-hepatotoxic activity
was evaluated via measuring serum markers level viz. alanine aminotransferase (ALT), aspartate aminotransferase (AST), and
alkaline phosphatase (ALP) in CCl4-induced hepatotoxicity in rats. In vitro cytotoxicity of the different extracts was estimated
for liver cancer cell line (HEPG2) adopting Sulforhodamine B stain assay. T.ET.L. exhibited significantly potent anti-oxidant and
anti-hepatotoxic activities, while T.ET.S. showed the highest cytotoxic activity. Through biological guided fractionation, leaves and
stems were subjected to successive solvent extraction, whereas the leaves ethyl acetate (Et.Ac.L.) and the stems ethanol 70%
(Et.70%S.) extracts showed highly potent activities. Thus, different chromatographic techniques were performed on Et.Ac.L. and
Et.70%S. extracts leading to the isolation of five bioactive metabolites. Three flavonoids were isolated from Et.Ac.L.; genistein-
7-O-rutinoside (1), formononetin-7-O-rutinoside (2) and myricetin (3), while orobol-7-O-glucoside (4) and hesperidin (5) were
isolated from Et.70%S. This work demonstrated the importance of the plant as a promising anti-oxidant, anti-hepatotoxic and
cytotoxic product for nutraceutical use.
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Introduction
Nyctagineaceae comprises a number of popular flowering 
ornamentals, including Bougainvil-lea species which occur 
mainly in tropical and subtropical re-gions [1]. Bougainvillea 
spectabilis Willd. is one of the most commonly known 
species of the genus Bougainvillea. Through
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phytochemical analysis, phytoconstituents including alkaloids,
flavonoids, glycosides, saponins, steroids, terpenoids and tan-
nins [2] were detected in the different extracts of leaves, stems
and flowers of B. spectabilis Willd. Srinivasan and Subrama-
nian [3] isolated and characterized isorhamnetin and quercetin
from fresh flowers with white bracts, while quercetin and
caffeic acid were isolated from leaves and stems, respec-
tively [4, 5]. Furthermore, pinitol was reported to be isolated
from the leaves [6] and the stem bark [7] of the plant. In a pre-
vious communication, the influence of plant growth regulators
on calluogenesis and secondary metabolites production in B.
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spectabilis Willd. callus cultures was studied providing various
successful cultures that could be a potential source for different
metabolites [8].
Pharmacological studies revealed that the leaves and roots
of B. spectabilis Willd. possessed anti-viral activity [9], while
leaves extracts showed good anti-hyperglycemic activity [10].
Furthermore, the plant extracts showed anti-bacterial [11] and
anti-fertility [12] activities. Very few studies were traced con-
cerning the anti-hyperlipidemic [13] anti-oxidant [14], anti-
inflammatory [15], anti-hepatotoxic [16] and cytotoxic [17] ac-
tivities.
As free radicals and oxidative stress are involved in the pro-
duction of various diseases in human, as hepatotoxiciy and can-
cer, the authors are concerned with the efficacy of the stud-
ied plant in preventing the free radical-induced tissue damage.
Therefore, this study was planned to assess anti-oxidant, anti-
hepatotoxic and cytotoxic activities for the extracts of leaves,
stems and flowers of B. spectabillis Willd. cultivated in Egypt
and to determine the biological active extracts in a trial to isolate
the main metabolites from them.
Materials and Methods
Plant material
The leaves, stems and flowers (with purple bracts) of
Bougainvillea spectabilis Willd. were collected from the Ex-
perimental Station of Medicinal Plants, Pharmacognosy De-
partment, Faculty of Pharmacy, Cairo University, Giza, Egypt,
during the flowering stage from March to July (2009-2010).
The plant was identified by Mrs. Thérèse Labib, a consultant of
Orman Botanical Garden, Giza, Egypt and its identity was veri-
fied by Dr. Mohamed El Gebaly (Plant Taxonomy and Egyptian
Flora Department, National Research Center, Dokki, Giza). A
voucher specimen (# 2982016) has been deposited at the Mu-
seum of the Pharmacognosy Department, Faculty of Pharmacy,
Cairo University.
Preparation of total ethanol extracts
About one kilogram of each of the powdered leaves and stems
were separately extracted by ethanol (70 %) by using Soxh-
let apparatus [18], till exhaustion, to yield T.ET.L. and T.ET.S.,
respectively. Fresh flowers (1 Kg) were exhaustively extracted
with ethanol (70 %) but by cold maceration (as concluded by the
authors, during the course of this work, heating demonstrated
degradation for some of their metabolites) to provide T.ET.F.
The obtained extracts were completely dried, under vaccum, us-
ing rotatory evaporator (Buchi, Germany) at 40◦C and stored at
low temperature (-4◦C).
Preparation of successive extracts
The air dried powdered leaves and stems (800 g, each) were
separately extracted by petroleum ether followed by methylene
chloride, ethyl acetate and 70 % ethanol using Soxhlet appara-
tus [19]. The obtained successive extracts were evaporated to
dryness, under vaccum, and stored in sealed glass vials at -4◦C
for biological and phytochemical studies.
Chemicals, drugs and biochemical kits
All solvents were of analytical grade; absolute ethanol,
petroleum ether (60-80◦C), methylene chloride, ethyl acetate,
methanol, formic acid, acetic acid and n-butanol. Alloxan and
carbon tetrachloride were purchased (Sigma Co., USA); vitamin
E was available in the form of gelatinous capsules, each con-
tains 400 mg dl α-tocopherol acetate (Pharco Pharmaceutical
Co., A.R.E.); Silymarin (Sedico Pharmaceutical Co., 6 Octo-
ber city, Egypt). Glutathione kits for assessment of antioxidant
activity (Wak-Chemie Medical, Germany); transaminase kits
for assessment of serum aspartate aminotransferase, alanine
aminotransferase and alkaline phosphatase (Biomerieux Co.,
France).
Experimental animals
Male mice (20-25 g) and adult male albino rats (Sprauge Dawely
strain of 130-150g) were obtained from the National Research
Centre, Dokki, Giza, Egypt. The animals were kept under the
same hygienic conditions and fed on standard laboratory diet
[normal diet consisted of vitamin mixture (1%), mineral mixture
(4%), corn oil (10%), sucrose (20%), cellulose (0.2%), casein
95% pure (10.5%) and starch (54.3%)] and provided with water
ad libitum. All animal procedures followed were in accordance
with the regulations of the Animal Ethics Committee of the Na-
tional Research Centre and with those of the Code of Ethics of
the World Medical Association (Declaration of Helsinki).
Toxicological and Pharmacological evaluation
The following toxicological and pharmacological studies were
performed on T.ET.L., T.ET.S., T.ET.F. in addition to the suc-
cessive extracts (petroleum ether, methylene chloride, ethyl ac-
etate and 70% ethanol extracts) of the selected bioactive organ
of B. spectabilis Willd. The median lethal dose (LD50) was es-
timated by determining the minimal dose that kills all animals
and the maximal dose that fails to kill any animal, then sev-
eral doses were chosen in between these two doses, each was
injected subcutaneously in a group of 6 mice which were ob-
served for 24 h for symptoms of toxicity and mortality [20].
Drug therapeutic dose was calculated according to Paget and
Barnes [21]. Furthermore, the pharmacological potentialities
were evaluated according to the published procedures includ-
ing in vivo anti-oxidant [22] which was assessed by measuring
serum glutathione (GSH) of alloxan-induced diabetic rats. Addi-
tionally, the anti-hepatotoxic activity [23] was evaluated by mon-
itoring serum levels of alanine aminotransferase (ALT), aspar-
tate aminotransferase (AST), and alkaline phosphatase (ALP) in
CCl4-induced hepatotoxic rats, before and after induction. The
effects produced were, in each case, compared with those of ap-
propriate reference drugs. Results for these biological activites
are presented in Table (1) and Figure (1).
Moreover, aliquots (5-50 µg/ml) of DMSO solutions of the
total ethanol extracts and the successive extracts of the selected
bioactive organ (petroleum ether, methylene chloride, ethyl ac-
etate and 70% ethanol extracts) were separately subjected to
evaluation of the cytotoxic activity against liver cancer cell line
(HEPG2) [24]. Results are illustrated in Figure 2.
Experimental data were presented as mean ± standard error
and were statistically analyzed using ANOVA and paired sam-
ples t-test via SPSS (version 20).
Phytochemical study
General experimental conditions
Solvent systems for paper chromatography (PC) included S1 (n-
Butanol: acetic acid: water; 4: 1: 5v/v/v) (upper phase) using
Whatman sheets No. 3 (Whatman Ltd., England). Precoated sil-
ica gel plates 60 F254 (Reide-de Haen, Germany) were used for
thin layer chromatography (TLC) by applying the solvent sys-
tems S2 (ethyl acetate: formic acid: acetic acid: water; 100: 11:
11: 27v/v/v/v) and S3 (ethyl acetate: methanol: water; 100: 13.5:
10 v/v/v). Melting points for isolated compounds were carried
out on an Electrothermal 9100 apparatus (Electrothermal En-
gineering Ltd, Essex, England). EI-mass spectra were recorded
using a Finnigan MAT SSQ 7000 single-stage quadrupole mass
spectrometer and electron energy of 70 eV. NMR spectra (chem-
ical shifts in ppm, coupling constants in Hz) were recorded on
NMR Joel GLM, Joel TMS route instrument, 500 MHZ (Japan)
using DMSO-d6 as a solvent.
Isolation and identification of the compounds
Biological screening of the investigated extracts revealed that
the ethyl acetate extract of the leaves (Et.Ac.L.) possessed po-
tent anti-oxidant and anti-hepatotoxic activities, whereas ethanol
70% extract of the stems (Et.70%S.) showed highest liver cy-
totoxic activity. Therefore, these extracts were subjected to
fractionation for isolation of some of the constituents. Chro-
matographic fractionation of Et.Ac.L. and Et.70%S. (5g, each)
was performed using PC and S1 as solvent system. Each chro-
matogram was visualized under UV before and after spraying
with1% aluminium chloride or exposure to ammonia vapour.
Three major spots were detected (Rf : 0.08, 0.14 and 0.32 in sys-
tem S1) in case of Et.Ac.L, while Et.70%S. showed two major
spots (Rf : 0.18 and 0.22 in system S1). Each compound was
purified by repeated preparative TLC using S2 as solvent system
and 1% aluminium chloride as spraying reagent. Final purifica-
tion was performed by recrystallization using methanol to afford
three pure compounds (1-3) from Et.Ac.L. and two compounds
(4-5) from Et.70%S.
Results
Soxhlet extraction of the leaves and stems yielded a dark green
residue (335 g) and a greenish residue (205 g), respectively.
Meanwhile, a purple residue (202 g) from the flowers was af-
forded. Furthermore, the successive extracts of the leaves were
dried to provide petroleum ether (fatty dark green residue, 44.5
g), methylene chloride (dark green residue, 23.1 g), ethyl acetate
(yellow residue, 20.8 g) and 70 % ethanol (red residue, 180 g)
extracts. Additionally, the stems yielded extracts viz. petroleum
ether (fatty dark green residue, 8.4 g), methylene chloride (dark
green residue, 16.0 g), ethyl acetate (yellow residue, 20.5 g) and
70 % ethanol (red residue, 130 g) extracts.
The median lethal dose (LD50)
LD50 of T.ET.L., T.ET.S. and T.ET.F. were 6.38, 6.20 and 5.75
g/kg b.wt., respectively.
Anti-oxidant activity
The serum glutathione level was greatly reduced after induc-
tion of diabetes (Figure 1) which was returned close to its
normal level by treatment of animals with vitamin E (% of
change=1.10).
Likewise, T.ET.L. extract showed the highest anti-oxidant
activity as it restored the level of serum glutathione (% of
change=4.14). Furthermore, Et.Ac.L. exhibited the highest ac-
tivity (% of change=8.60) among the successive leaves extracts.
Anti-hepatotoxic activity
Pretreatment with T.ET.L., T.ET.S. and T.ET.F. (100 mg/kg
b.wt.) before liver damage, showed no changes in AST, ALT
and ALP serum levels, while the CCl4 intoxication resulted in
a significant increase in their levels in all tested groups.
Treatment with T.ET.L., T.ET.S. and T.ET.F. significantly
prevented CCl4-induced elevation in the serum levels of AST,
ALT and ALP compared to the negative control (Table 1).

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Diagram 1: Structure of Different compounds
and 20.64% for AST, ALT and ALP, respectively, compared
to the reference drug (35.82, 26.45 and 64.14%, respectively).
Likewise, the successive leaves extracts showed marked activity
and restored the levels of AST, ALT and ALP; the most power-
ful being Et.Ac.L. which showed % of change= 36.30% (AST),
33.70% (ALT) and 10.25% (ALP).
Cytotoxic activity
The investigated extracts of B. spectabilis Willd. exhibited vari-
able activities against liver cancer cell line (HEPG2) com-
pared to the reference anticancer drug; doxorubicin (Figure 2).
T.ET.S. appeared to be the most active (IC50 = 5.4 µg/ml), be-
ing almost comparable to doxorubicin (IC50 = 4 µg/ml), while
T.ET.L. and T.ET.F. showed weak activity (IC50=31.4 and49.5
µg/ml,respectively). Furthermore, investigation of successive
stems extracts revealed that Et.70%S. exhibited the highest ac-
tivity (IC50 = 19.1 µg/ml), while petroleum ether and ethyl ac-
etate extracts showed moderate activity ( IC50 = 21.3 and 23.3
µg/ml, respectively) and the methylene chloride extract showed
very weak activity.
Isolated compounds
Five compounds (1-5) were isolated from leaves and stems of B.
spectabilis Willd.
Compound (1): 70 mg, yellow crystals; Rf in S1=0.08;
m.p.=250-251˚ C; (EI/MS) 577(M-H), 431, 270(100%);1H-
NMR (500 MHz, DMSO): δ 8.3 (1H, s,H-2), 7.66 (2H, m,
H-2´& 6´), 7.00 (2H, m, H-3´& 5´), 6.6(1H, d, H-8), 6.2(1H, d,
H-6), 5.15(1H, d, H-1´´), 4.32(1H, s, H-1´´´), 3.7-3.1(m, remain-
ing rutinoside protons), 0.99(d, protons of CH3-6´´´). 13C-NMR
(500 MHz, DMSO): δ 180(C-4), 165(C-7), 162(C-4´), 157(C-
5), 155(C-9), 154(C-2), 128(C-2´&6´), 122(C-1´), 121(C-3),
115(C-3´&5´), 102(C-10), 101(C-1´´), 98(C-1´´´& 6), 92(C-
8), 76.5(C-3´´), 75.5(C-5´´), 72.4(C-2´´& 4´´´),72.1(C-3´´´),
71.6(C-2´´´), 70.9(C-4´´), 69.8(C-6´´), 18(C-6´´´).
Compound (2): 50 mg, yellow amorphous powder; Rf in
S1 =0.14; m.p.=230-231˚ C; 1H-NMR (500 MHz, DMSO)
: δ 9.2 (1H, s, H-2), 7.998 (1H, m, H-5), 7.793 (2H, d, H-
2´&6´), 7.196 (1H, m, H-6), 6.864(2H, d, H-3´&5´), 6.8 (1H,
m, H-8), 5.3(1H, m, H-1´´), 4.4(1H, s, H-1´´´), 3.691(s, protons
of O-CH3), 3.5-3.1(m, remaining rutinoside protons), 0.80(d,
protons of CH3-6´´´).13C-NMR (500 MHz, DMSO): δ 174(C-
4), 161(C-7), 159(C-4´), 157(C-9), 153(C-2), 130(C-2´&6´),
126.668(C-5), 124(C-1´), 123(C-3), 119(C-10), 114(C-6),
114(C-3´&5´), 103(C-8), 101.915(C-1´´), 98(C-1´´´), 76.5(C-
3´´), 75.293(C-5´´), 72.321(C-2´´&4´´´),72.1(C-3´´´), 71.851(C-
2´´´), 70.913(C-4´´), 70.052(C-6´´), 59.479(O-CH3) and 18(C-
6´´´).
Compound (3): 60 mg, yellow amorphous powder; Rf in
S1= 0.32; m.p.=357-360˚ C; (EI/MS) 317(M-H); 1H-NMR (500
MHz, DMSO): δ 7.3 (2H, s, H-2´and H-6), 6.37 (1H, d, H-8),
6.18 (1H, d, H-6). 13C-NMR(500 MHz, DMSO): δ 175(C-4),
163(C-7), 160(C-5), 155(C-9), 146(C-2), 145(C-3´&5´), 131(C-
3 &4´), 120(C-1´), 107(C-2´&6´), 102(C-10), 96(C-6), 92(C-8).
Compound (4): 20 mg, yellow amorphous powder (MeOH);
Rf in S1 =0.18; m.p.=180-181˚ C; 1H-NMR (500 MHz,
DMSO): δ 9.2(1H, s, H-2), 7.672 (1H, d, H-2´), 7.2(1H, m,
H-6´), 7.018(1H, d, H-5´), 6.5 (1H, br. s, H-8), 6.2(1H, br. s,
H-6), 5.17 (1H, dd, H-1´´), 3.5 (m, protons of glucose).
Compound (5): 40 mg, yellow amorphous powder; Rf in
S1= 0.22; m.p.= 251-254˚ C; 1H-NMR (500 MHz, DMSO):
δ 6.9(2H, d, H-2´&6´), 6.7(1H, d, H-5´), 6.4(1H, d, H-8),
6.24(1H, d, H-6), 5.2 (1H, dd, H-2), 4.824 (1H, d, H-1´´),
4.2 (1H, d, H-1´´´), 3.81 (s, protons of O-CH3), 3.1(1H,
m, H-3), 0.8 (d, protons of CH3-6´´´).13C-NMR (500 MHz,
DMSO): δ 208(C-4), 166(C-7), 162(C-5&9), 148(C-3´), 146(C-
4´), 130(C-1´), 118(C-6´),114(C-2´), 110(C-5´), 104.135(C-
10), 101.896(C-1´´), 99(C-1´´´), 96.803(C-6), 95.89(C-8),
76.621(C-3´´), 75.266(C-5´´), 72.306(C-2´´& 4´´´), 72.268(C-
3´´´), 71.829(C-2´´´), 71.828(C-2), 70.894(C-4´´),70.025(C-
6´´), 59.468(O-CH3), 40.281(C-3), 18(C-6´´´).
Discussion
The total ethanol extracts of the leaves , stems and flowers could
be considered non-toxic according to Lorke [25]. T.ET.L. extract
exhibited the highest anti-oxidant activity and that agreed with
Sandeep et al. [11] who reported the methanol and aqueous ex-
tracts of B. spectabilis Willd. leaves to have potential in vitro an-
tioxidant activity. Meanwhile, T.ET.L. and T.ET.S. extracts dis-
played the highest activities as anti-hepatotoxic and cytotoxic,
respectively.
The isolated compounds were identified based on their
UV, EI/MS and NMR (1H and 13C ) spectra and comparison
with the published data as: (1) genestein 7-O- rutinoside [26],
(2) formononetin-7-O-rutinoside [27], (3) myricetin [28] , (4)
orobol-7-O-glucoside [29] and (5) hesperidin [30]. To the best
of our knowledge, this is the first report for the isolation of
formononetin 7-O-rutinoside, genestein 7-O-rutinoside and
myricetin from leaves in addition to orobol 7-O-glucoside and
hesperidin from the stems of Bougainvillea spectabilis Willd..
Alloxan and carbon tetrachloride were used in this study as
free radicals and oxidative stress inducers. During the course of
this work, the studied plant extracts were shown to act as rad-
ical scavengers. Additionally, it revealed the inclusion of vari-
ous flavonoids. Because of the high reactivity of the hydroxyl
groups incorporated in the structure of the flavonoids, free rad-
icals are made inactive. Flavonoids as antioxidants may of-
fer resistance against oxidative stress by scavenging free rad-
icals and thus preventing the disease [31]. The anti-oxidant
activity of the extracts could be attributed to the presence of
myricetin [32], formononetin-7-O-rutinoside [33] and genestein
7-O-rutinoside [34]. This agreed with Mishra et al. [16] who re-
ported that the anti-hepatotoxic activity of the studied plant is
due to the availability of sufficient amounts of flavonids and phe-
nolic compounds included in its extracts. Thus, such bioactive
metabolites contribute to the anti-hepatotoxic activity through
their antioxidative effect which is claimed to be one of the mech-
anisms of hepatoprotection [35]. Moreover, the potent cytotoxic
activity of T.ET.S. on liver cell line may be attributed to the
presence of hesperidin [36] and other flavonoids. It has been
stated that flavonoids, as antioxidants, can inhibit carcinogenesis
through damage of reactive oxygen species which is proposed to
be involved in carcinogenesis [37], although the antitumor activ-
ity of flavonoids is still a point of discussion and the antioxidant
activity is frequently inadequate.
From the findings of this study, it is obvious that the total
ethanol leaves extract of B. spectabilis Willd. exerted signifi-
cant anti-oxidant and anti-hepatotoxic activities, while the total
ethanol stems extract exhibited a potent liver cytotoxic activity.
Therefore, it could be used as a successful candidate for herbal
formulations prescribed for complementary treatment of a wide
variety of ailments such as liver toxicity, as well as, liver cancer.
However, further laboratory and clinical trials should be carried
out to complete the profile of the plant in order to introduce it as
a neutraceutical drug.
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